ANI PHARMACEUTICALS INC — Director's Dealing 2020

Apr 8, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2020-04-06

Reporting Person: Marken James G. (SVP Ops & Prod Dev)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-04-06	Common Stock	F	337	$43.22	Disposed	60893	Direct
2020-04-07	Common Stock	F	144	$43.93	Disposed	60749	Direct

Footnotes

F1: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 1,100 shares of restricted stock, which was previously reported.

F2: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 469 shares of restricted stock, which was previously reported.